KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Interest & Investment Income: 2009-2021

Historic Interest & Investment Income for Novavax (NVAX) over the last 13 years, with Dec 2021 value amounting to $303,000.

  • Novavax's Interest & Investment Income rose 113.38% to $303,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year increase of 34.38%. This contributed to the annual value of $1.4 million for FY2021, which is 34.52% up from last year.
  • As of Q4 2021, Novavax's Interest & Investment Income stood at $303,000, which was down 8.18% from $330,000 recorded in Q3 2021.
  • Novavax's Interest & Investment Income's 5-year high stood at $807,000 during Q2 2018, with a 5-year trough of $140,000 in Q3 2020.
  • In the last 3 years, Novavax's Interest & Investment Income had a median value of $336,000 in 2019 and averaged $324,250.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 59.06% in 2020, then skyrocketed by 135.71% in 2021.
  • Novavax's Interest & Investment Income (Quarterly) stood at $418,000 in 2017, then spiked by 39.71% to $584,000 in 2018, then plummeted by 52.74% to $276,000 in 2019, then slumped by 48.55% to $142,000 in 2020, then surged by 113.38% to $303,000 in 2021.
  • Its Interest & Investment Income stands at $303,000 for Q4 2021, versus $330,000 for Q3 2021 and $369,000 for Q2 2021.